Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia

Fundamental and Clinical Pharmacology

Volumn 23, Issue 5, 2009, Pages 557-566

  Kaur, Baljinder ^a   Singh, Nirmal ^a   Jaggi, Amteshwar Singh ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Alzheimer; Dementia; Morris Water Maze; Pioglitazone; Streptozotocin

Indexed keywords

N(G) NITROARGININE METHYL ESTER; PIOGLITAZONE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD GLUCOSE; BRAIN; DEMENTIA; DISEASE MODELS, ANIMAL; GLUTATHIONE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; NITRIC OXIDE; PPAR GAMMA; STREPTOZOCIN; THIAZOLIDINEDIONES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 70049089859     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00708.x     Document Type: Article

References (73)

1. Ritchie K., Kildea D. Senile dementia "age-related" or "aging related"? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet (1995) 346 931 934.
2. Aevarson O., Skoog I. A population based study on the incidence of dementia disorders between 85 and 88 years of age. J. Am. Geriat. Soc. (1996) 44 455 460.
3. Butterfield D.A. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. (2004) 1000 1 7.
4. Gary E.G., Hsueh-Meei H. Oxidative stress in Alzheimer's disease. Neurobiol. Aging (2005) 26 575 578.
5. Kielian T., Drew P.D. Effects of PPAR γ agonists on central nervous system inflammation. J. Neurosci. Res. (2003) 71 315 325.
6. David S.G., Mark H.L.L., JoAnne M. Ciglitazone increases basal cytokine expression in the central nervous system of adult rats. Brain Res. (2005) 1034 139 146.
7. Bordet R. PPARs: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem. Soc. Trans. (2006) 34 1341 1346.
8. Roses A.D. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenic hypothesis (Alzheimer's disease). J. Pharmacogenomics (2007) 7 10 28.
9. Jing C., Ting A.T., Seed B. PPAR gamma agonists inhibit production of monocyte inflammatory cytokines. Nature (1998) 391 82 86.
10. Ricote M., Huang J.T., Welch J.S., Glass C.K. The peroxisome proloferator receptor gamma as a regulator of monocyte/macrophage function. J. Leukoc. Biol. (1999) 66 733 739.
11. Srinivasan K., Patole P.S., Kaul C.L., Ramarao P. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats methods find. Exp. Clin. Pharmacol. (2004) 26 327 333.
12. Diab A., Deng C., Smith J.D. et al. Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Delta (12, 14)-prostaglandin J (2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. (2002) 168 2508 2515.
13. Fiensein D.L., Galea E., Gavrilyuk V. et al. PPAR γ agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. (2002) 51 694 702.
14. Thomas D., Michael T.H., Magdalena S., Jhonnes D., Jorg B.S. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IkB induction and block of NFkB and iNOS activation. J. Neurochem. (2004) 88 494 501.
15. Juraj C. PPAR-γ: therapeutic target for ischemic stroke. Trends Pharmacol. Sci. (2007) 28 243 249.
16. Pathan A.R., Viswanad B., Sonkusare S.K., Ramarao P. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. (2006) 79 2209 2216.
17. Heneka M.T., Landreth G.E. PPARS in brain. Biochim. Biophys. Acta (2007) 1771 1031 1045.
18. Koshinaka K., Oshida Y., Han Y.-Q., Ohsawa I., Y S. The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats. Metabolism (2003) 53 22 27.
19. Jayesh B.M., Arvind N.P., Chitrang J.T., Balaraman R. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats. Vascul. Pharmacol. (2005) 43 260 266.
20. Sakurada T., Sakurada S., Katsuyama S., Sakurada C., No K.T., Terenius L. Noceceptin (1-7) antagonizes noceceptin induced hyperalgesia in mice. Br. J. Pharmacol. (1999) 128 941 944.
21. Morris R.G.M. Developments of a water maze procedure for studying spatial learning in the rats. J. Neurosci. Methods (1984) 11 47 60.
22. Parle M., Singh N. Animal models for testing memory. Asia Pacific J. Pharmacol. (2004) 16 101 120.
23. Shoham S., Bejar C., Kovalev E., Schorer-Apelbaum D., Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology (2007) 52 836 843.
24. Murali B., Upadhyaya U.M., Goyal R.K. Effect of chronic treatment with enicostemma littorale in non-insulin dependent diabetic (NIIDM) rats. J. Ethnopharmacol. (2002) 81 199 204.
25. Ellman G.L., Courtney K.D., Valentino A., Featherstone R.M. A new and rapid colometric determination of acetylcholinesterase activity. Biochem. Pharmacol. (1961) 7 88 95.
26. Okhawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animals tissue by thiobarbituric acid reaction. Anal. Biochem. (1979) 95 351 358.
27. Beutler E., Duron O., Kelly B.M. Improved methods for determination of blood glutathione. J. Lab. Clin. Med. (1963) 61 882 888.
28. Lowry O.H., Rosebrough N.J., Far A.L., Randall R.J. Protein measurement with folin-phenol reagent. J. Biol. Chem. (1951) 193 265 275.
29. Parle M., Singh N. Reversal of memory deficits by atorvastatin and simvastatin in rats. Yakugaku Zasshi (2007) 127 1125 1137.
30. Sharma B., Singh N., Singh M. Modulation of celecoxib and streptozotocin induced experimental dementia of Alzheimer's disease type by pitavastatin and donepezil. J. Psychopharmacol. (2008) 22 162 171.
31. Sharma B., Singh N., Singh M., Jaggi A.S. Exploitation of HIV protease inhibitor indinavir as a memory restorative agent in experimental dementia. Pharmacol. Biochem. Behav. (2008) 89 535 545.
32. Packard M.G., Teather L.A., Bazan N.G. Effect of intra-striated injections of platelet-activating factor and PAF antagonist BN 52021 on memory. Neurobiol. Learn. Mem. (1996) 66 176 182.
33. Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. (1998) 112 1199 1208. (Pubitemid 28519002)
34. Saxena G., Singh S.P., Agrawal R., Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur. J. Pharmacol. (2008) 581 283 289.
35. Saxena G., Singh S.P., Pal R., Singh S., Pratap R., Nath C. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol. Biochem. Behav. (2007) 86 797 805.
36. Natarajan A., Leelavinothan P., Ramkumar K.M. N-benzoyl-d-phenylalanine attenuates brain acetylcholinesterase in neonatal streptozotocin-diabetic rats. Basic Clin. Pharmacol. Toxicol. (2006) 99 246 250.
37. Sharma M., Gupta Y.K. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. (2001) 68 1021 1029.
38. Shoham S., Bejar C., Kovalev E., Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp. Neurol. (2003) 184 1043 1052.
39. Mayer G., Nitsch R., Hoyer S. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. (1990) 532 95 100.
40. Feillet-Coudray C., Rock E., Coudray C. et al. Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chim. Acta (1999) 284 31 43.
41. Reagan L.P., Magarinos A.M., Yee D.K. et al. Oxidative stress and HNE conjugation of GLUT 3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res. (2000) 862 292 300.
42. Smith K.J., Kapoor R., Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. (1999) 9 69 92.
43. Braak H., Del Tredici K., Schultz C., Braak E. Vulnerability of selective neuronal types to Alzheimer's disease. Ann. N. Y. Acad. Sci. (2000) 924 53 61.
44. Hoyer S., Muller D., Plaschke K. Desensitization of brain insulin receptor: effect on glucose/energy and related metabolism. J. Neural Transm. (1994) 44 (Suppl.) 259 268.
45. Hoyer S. The aging brain changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late onset sporadic Alzheimer's disease (SAD): a mini review. J. Neural Transm. (2000) 109 991 1002.
46. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer's disease: an update. J. Neural Transm. (2000) 109 (Suppl) 341 360.
47. Hoyer S., Lee S.K., Loffler T., Schliebs R. Inhibition of the neuronal insulin receptor an in vivo model for sporadic Alzheimer disease. Ann. N. Y. Acad. Sci. (2000) 920 256 258.
48. Ishida H., Takizawa M., Ozawa S. et al. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: possible protection of beta cells from oxidative stress. Metabolism (2004) 53 488 494.
49. Nikolaos P., Antonello E.R., Sara M.B., Silvano G.C., Eugenio E.M. Molsidomine antagonizes L-NAME-induced acquisition deficits in a recognition memory task in the rat. Pharmacol. Res. (2003) 47 311 315.
50. Da Cunha I.C., José R.F., Orlandi Pereira L. et al. The role of nitric oxide in emotional learning of rats in the plus-maze. Physiol. Behav. (2005) 84 351 358.
51. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res. (1998) 799 215 219.
52. Paul V., Reddy L., Ekambaram P. Prevention of picrotoxin convulsions-induced learning and memory impairment by nitric oxide increasing dose of L-arginine in rats. Pharmacol. Biochem. Behav. (2003) 75 329 334.
53. Pitsikas N. Effects of scopolamine and L-NAME on rats' performance in the object location test. Behav. Brain Res. (2007) 179 294 298.
54. Kamii H., Mikawa S., Murakami K. et al. Effects of nitric oxide synthase inhibition on brain infarction in SOD-1-transgenic mice following transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. (1996) 16 1153 1157.
55. Bannermann D.M., Chapman P.F., Kelly P.A.T., Butcher S.P., Morris R.G.M. Inhibition of nitric oxide synthase does not impair spatial learning. J. Neurosci. (1994) 14 7404 7414.
56. Bannermann D.M., Chapman P.F., Kelly P.A.T., Butcher S.P., Morris R.G.M. Inhibition of nitric oxide synthase does not prevent the induction of long term potentiation in vivo. J. Neurosci. (1994) 14 7415 7425.
57. Hawkins R.D., Son H., Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog. Brain Res. (1998) 118 155 172.
58. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. (2001) 64 51 68.
59. Kopt S.R., Benton R.S., Kalfin R., Giovannini M.G., Pepeu G. NOS inhibitors decreases cortical acetylcholine release and impairs retention of a conditioned response. Brain Res. (2001) 894 141 144.
60. Reddy P.L., Rajasekaran K., Paul V. Evidence for an involvement of nitric oxide in memory of shock avoidance task in rats. Indian J. Physiol. Pharmacol. (2002) 46 119 122.
61. Thomas T. Monoamine oxidase-B-inhibitors in the treatment of Alzheimer's disease. Neurobiol. Aging (2000) 21 343 348.
62. Pitsikas N., Rigamonti A.E., Cella S.G., Locatelli V., Sala M., Muller E.E. Effect of molsidomine on scopolamine induced amnesia and hypermotility in the rat. Eur. J. Pharmacol. (2001) 426 193 200.
63. Prast H., Philippu A. Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmacol. (1992) 216 139 144.
64. Prast H., Fischer H., Werner E., Werner-Felmayer G., Philippu A. Nitric oxide modulates the release of acetylcholine in the ventral striatum of the freely moving rats. Naunyn-Schmiedebergs Arch. Pharmacol. (1995) 352 67 72.
65. Prast H., Tran M.H., Fischer H., Philippu A. Nitric oxide induced release of acetylcholine in the nucleus accumbens: role of cyclic GMP, glutamate and GABA. J. Neurochem. (1998) 71 266 273.
66. Ohkuma S., Katsura M., Guo J.L., Hasegawa T., Kuriyama K. Involvement of peroxynitrite in N-methyl-D-aspartate- and sodium nitroprusside-induced release of acetylcholine from mouse cerebral cortical neurons. Brain Res. Mol. Brain Res. (1995) 31 185 193.
67. Rubbo H., Radi R., Trujillo M. et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. (1994) 249 26066 26075.
68. Chiueh C.C. Neuroprotective properties of nitric oxide. Ann. N. Y. Acad. Sci. (1999) 890 301 311.
69. Kelly E.E., Wagner B.A., Buettner G.R., Burns C.P. Nitric oxide inhibits iron-induced lipid peroxidation in HL-60 cells. Arch. Biochem. Biophys. (1999) 370 97 104.
70. Pannu R., Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem. Int. (2006) 49 170 182.
71. Hummel S.G., Fischer A.J., Martin S.M., Schafer F.Q., Buettner G.R. Nitric oxide as a cellular antioxidant: a little goes a long way. Free Radic. Biol. Med. (2006) 40 501 506.
72. Zhao W.Q., Alkon D.L. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. (2001) 177 125 134.
73. Gerozissis K., Rouch C., Lemierre S., Nicolaidis S., Orosco M. A potential role of central insulin in learning and memory related to feeding. Cell. Mol. Neurobiol. (2001) 21 389 401.